Hetero Labs Limited (Unit V) recalls Pantoprazole Sodium
- Published
- 29 Apr 2026
- Units affected
- 4,740 1,000-count bottles.
- Agency
- FDA
- Country
- United States
The hazard
Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Pantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: Hetero, Hetero Labs Limited, Unit V, Polepally, Jadcherta, Mahabubager-509 301, India, NDC 31722-713-10
- Brand / company
- Hetero Labs Limited (Unit V)
- Codes / lots
- Batch # FD253967, Exp Date: 06/26/2027
- Distribution
- Nationwide in the USA.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 29 Apr 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.